Ifosfamide tolerance in osteosarcoma pat
โ
Canpolat, Cengiz; Pearson, Peggy; Robertson, Resa; Jaffe, Norman
๐
Article
๐
1996
๐
John Wiley and Sons
๐
English
โ 901 KB
We attempted to ascertain renal, hematologic, and neurologic tolerance to ifosfamide (IFX) in pediatric patients previously treated with large single and cumulative doses of cis-Diamminedichloroplatinum-ll (CDP) for osteosarcoma (0s). Twenty 0 s patients were treated with CDP: initially 150 mgh'was